Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Polyp Biopsy Market Value Growth And Long-Term Outlook#_x000D_
The polyp biopsy market size has experienced significant growth in recent years. It is anticipated to expand from $1.39 billion in 2025 to $1.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This market’s historical growth can be attributed to factors such as the increasing occurrence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the expansion of screening programs, heightened awareness regarding the benefits of early diagnosis, and the establishment of more specialty clinics._x000D_
_x000D_
The polyp biopsy market size is anticipated to demonstrate significant expansion in the coming years. It is projected to achieve a value of $2.06 billion in 2030, progressing at a compound annual growth rate (CAGR) of 8.2%. The increase expected during this forecast period can be attributed to several factors, including AI-assisted biopsy procedures, the utilization of minimally invasive techniques, a broader adoption by hospitals and diagnostic laboratories, integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Prominent trends observed in the forecast timeframe include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (emr)._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Polyp Biopsy Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The growing occurrence of colorectal cancer is anticipated to drive expansion in the polyp biopsy market in the coming years. This malignant condition, colorectal cancer, develops in the colon or rectum due to the unregulated proliferation of epithelial cells within the large intestine, known for its capacity to infiltrate adjacent tissues and spread to other parts of the body. A key factor contributing to this rise in colorectal cancer cases is prevalent dietary habits rich in processed items and lacking fiber, which can lead to persistent inflammation, changes in gut bacteria, and foster the formation of precancerous growths capable of evolving into cancer. Polyp biopsy plays a crucial role in lessening the effects of the increasing incidence of colorectal cancer by allowing for the early identification and microscopic assessment of abnormal lesions, thus facilitating prompt treatment and hindering the disease’s advancement. As an illustration, the American Cancer Society (ACS), a US-based non-profit, forecasts that in 2025, approximately 107,320 new cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the United States, with an estimated 52,900 deaths attributed to these cancers. Consequently, the escalating incidence of colorectal cancer is fueling the expansion of the polyp biopsy market._x000D_
_x000D_
#Polyp Biopsy Market Segmentation And Category Overview#_x000D_
The polyp biopsy market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy_x000D_
2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy_x000D_
3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications_x000D_
4) By End-User: Hospitals, Specialty Clinics_x000D_
_x000D_
Subsegments:_x000D_
1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy_x000D_
2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy_x000D_
3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy_x000D_
_x000D_
#Polyp Biopsy Market Trends Redefining Industry Growth#_x000D_
Leading companies in the polyp biopsy market are concentrating on developing innovative advancements, such as AI-assisted detection systems, to improve the identification of colorectal polyps and facilitate the early recognition of potential cancerous lesions. An AI-assisted detection system is a technology designed to analyze medical imaging in real-time, pinpointing potential abnormalities and issuing visual alerts to clinicians, thereby supporting clinical decision-making without requiring therapeutic interventions. For example, in September 2024, Odin Medical Ltd., a US-based medical technology company associated with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. The CADDIE device uses cloud-based artificial intelligence to analyze colonoscopy video live and emphasize areas with suspected colorectal polyps, enabling endoscopists to make informed choices during procedures. Clinical trials have indicated that the system enhances the adenoma detection rate without increasing procedural time or risk, emphasizing its potential to improve early detection and patient care._x000D_
_x000D_
#Polyp Biopsy Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical _x000D_
_x000D_
#View The Full Polyp Biopsy Market Report:#_x000D_
_x000D_
#Polyp Biopsy Market Geographic Distribution And Regional Opportunities#_x000D_
North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.